Wilson's disease: The scourge of copper

Journal of Hepatology

Volumn 28, Issue 4, 1998, Pages 734-739

  Gitlin, Norman ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; PENICILLAMINE; TETRATHIOMOLYBDIC ACID; TRIENTINE; ZINC;

CHRONIC HEPATITIS; DIET THERAPY; ENDOCRINE DISEASE; EYE DISEASE; HEMOLYSIS; HUMAN; KIDNEY DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; NEUROLOGIC DISEASE; ONSET AGE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; WILSON DISEASE;

EID: 0031981213     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80302-4     Document Type: Review

References (46)

1. Wilson SAK. Hyperlenticular degeneration and cirrhosis. Brain. 34:1912;292.
2. Maier-Dobersberger T, Mannhalter C, Rack S, Granditsch G, Kaserer K, Korninger L, et al. Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis. Gastroenterology. 109:1995;2015-2018.
3. Frydman M, Bonne-Tamir B, Farrer L, Conneally PM, Magazanik A, Ashbel S, et al. Assignment of the gene for Wilson's disease to chromosome 13. Proc Natl Acad Sci USA. 82:1985;1819-1821.
4. Bull PC, Thomas GR, Rommens JM, Forbes JR, Wilson Cox D. The Wilson's disease gene is a putative copper transporting P-type. ATPase similar to the Menkes gene. Nat Genet. 5:1993;327-337.
5. Tanzi RE, Petrukhn K, Chernov I, Pellequer JL, Wasco W, Ross B, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet. 5:1993;344-350.
6. Schoen RE, Sternlieb I. Clinical aspects of Wilson's disease. Am J Gastroenterol. 85:1990;1453-1457.
7. Fitzgerald MA, Gross JB, Goldstein NP, Wahner HW, McCall JT. Wilson's disease (hepatolenticular degeneration) of late adult onset. Mayo Clin Proc. 50:1975;438-442.
8. Marsden CD. Wilson's disease. Q J Med. 65:1987;959-966.
9. Steindl P Ferenci P, Dienes HP, Grimm G, Pabinger I, Madl C, et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology. 113:1997;212-218.
10. Stremmel W, Meyerrose KM, Niederau C, Hefter H, Kreuzpaintner Strohmeyer G. Wilson's disease clinical presentation, treatment, and survival. Ann Intern Med. 115:1991;720-726.
11. Wiebers DO, Hollenhorst RW, Goldstein NP. The ophthalmologic manifestations of Wilson's disease. Mayo Clin Proc. 52:1977;409-416.
12. Fleming CR, Dickson ER, Hollenhorst RW, Goldstein NP, McCall JT, Baggenstoss AH. Pigmented corneal rings in a patient with primary biliary cirrhosis. Gastroenterology. 69:1975;220-225.
13. Fleming CR, Dickson ER, Wahner HW, Hollenhorst RW, McCall JT. Pigmented corneal rings in non-Wilsonian liver disease. Ann Intern Med. 86:1977;285-288.
14. Jones EA, Rabin L, Buckley CH, et al. Progressive intrahepatic cholestasis of infancy and childhood: a clinico-pathological study of a patient surviving to the age of 18 years. Gastroenterology. 71:1976;675-682.
15. Kaplinsky C, Sternlieb I, Javitt N, Rotem Y. Familial cholestatic cirrhosis associated with Kayser-Fleischer rings. Pediatrics. 65:1980;782-788.
16. Rimola A, Bruguera M, Rodes J. Kayser-Fleischer-like ring in a cryptogenic cirrhosis. Arch Intern Med. 138:1978;1857-1858.
17. McCullough AJ, Fleming CR, Thistle JL, Baldus WP, Ludwig J, McCall JT, et al. Diagnosis of Wilson's disease presenting as fulminant hepatic failure. Gastroenterology. 84:1983;161-167.
18. Hartleb M, Zahorska-Markiewicz B, Ciesielski A. Wilson's disease presenting in sisters as fulminant hepatitis with hemolytic episodes. Am J Gastroenterol. 82:1987;549-551.
19. Berman DH, Leventhal RI, Gavaler JS, Cadoff EM, Van Thiel DH. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology. 100:1991;1129-1134.
20. Roche-Sicot J, Benhamou JP. Acute intravascular hemolysis and acute liver failure associated as a first manifestation of Wilson's disease. Ann Intern Med. 86:1997;301-303.
21. Scheinberg IH, Sternlieb I. Wilson's disease and the concentration of caeruloplasmin in serum. Lancet. i:1963;1420.
22. Deiss A, Lee GR, Cartwright GE. Hemolytic anemia in Wilson's disease. Ann Intern Med. 73:1979;413-418.
23. Conrad ME, Schwartz FD, Young AA. Infectious hepatitis - a generalized disease; a study of renal, gastrointestinal and hematologic abnormalities. Am J Med. 37:1964;789-801.
24. McIntyre N, Clink HM, Levi AJ, Cummings JN, Sherlock S. Hemolytic anemia in Wilson's disease. N Engl J Med. 276:1967;439-444.
25. Hillenbrand P, Parbhoo SP, Jedrychowski A, Sherlock S. Significance of intravascular coagulation and fibrinolysis in acute hepatic failure. Scand J Gastroenterol. 19:1973;133-134.
26. Chan TK, Todd D. Haemolysis complicating viral hepatitis in patients with glucose-6-phosphate dehydrogenase deficiency. Br Med J. 1:1975;131-133.
27. Todd JR, Thompson RH. Studies on chronic copper poisoning. Biochemical studies on blood of sheep during haemolytic crisis. Br Vet J. 119:1963;161-173.
28. Deiss A, Lynch RE, Lee GR, Cartwright GE. Long-term therapy of Wilson's disease. Ann Intern Med. 75:1971;57-65.
29. Schilsky ML, Scheinberg IH, Sternlieb I. Prognosis of Wilsonian chronic active hepatitis. Gastroenterology. 100:1991;762-767.
30. Carpenter TO, Carnes DL, Anast CS. Hypopartahyroidism in Wilson's disease. N Engl J Med. 309:1983;873-877.
31. Monfort J-C, Henault S, Merceron RE, et al. Maladie de Wilson révélée des troubles endocriniens: intérêt de la tomo-densitométrie et de la diurèse forcée. Nouv Presse Med. 7:1978;3552-3553.
32. Warnock CG. Hepatolenticular degeneration (Wilson's disease): a report of five cases with commentary. Ulster Med J. 21:1952;155-171.
33. Johansen K, Gregersen G. Glucose intolerance in Wilson's disease: normalization after treatment with penicillamine. Arch Intern Med. 129:1972;587-590.
34. Altschul R, Brown JS. Parathyroid insufficiency in Wilson's disease. Can Med Assoc J. 46:1942;237-240.
35. Wiebers D, Wilson DM, McLeod RA, Goldstein NP. Renal stones in Wilson's disease. Am J Med. 67:1979;249-254.
36. Stromeyer FW, Ishak KG. Histology of the liver in Wilson's disease. A study of 34 cases. Am J Clin Path. 73:1980;12-24.
37. Brewer GJ, Terry CA, Aisen AM, Hill GM. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol. 44:1987;490-494.
38. Steen VD, Blair S, Medsger TA. The toxicity of d-pencillamine in systemic sclerosis. Ann Intern Med. 104:1986;699-705.
39. Walshe JM. The management of pregnancy in Wilson's disease treated with Trientine. Q J Med. 58:1986;81-87.
40. Sternlieb I. Perspectives on Wilson's disease. Hepatology. 12:1990;1234-1239.
41. Yuzbasiyian-Gurkan V, Grider A, Nostrant T, Cousins RJ, Brewer GJ. Treatment of Wilson's disease with zinc X. Intestinal metallothionein induction. J Lab Clin Med. 120:1992;380-386.
42. Friedman LS. Zinc in the treatment of Wilson's disease: how it works. Gastroenterology. 104:1993;1566-1568.
43. Sternlieb I. Wilson's disease: indications for liver transplants. Hepatology. 4:1984;15-17. (Suppl).
44. Peleman RR, Gavaler JS, Van Thiel DH, Esquivel C, Gordon R, Iwatsuki S, et al. Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology. 7:1987;484-489.
45. Rakela J, Kurtz SB, McCarthy JT, Ludwig J, Ascher NL, Bloomer JR, et al. Fulminant Wilson's disease treated with postdilution hemofiltration and orthotopic liver transplantation. Gastroenterology. 90:1986;2004-2007.
46. Schilsky ML, Scheinberg IH, Sternlieb I. Liver transplantation for Wilson's disease: indication and outcome. Hepatology. 19:1994;583-587.